David Šálek

461 total citations
23 papers, 156 citations indexed

About

David Šálek is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, David Šálek has authored 23 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 8 papers in Genetics. Recurrent topics in David Šálek's work include Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). David Šálek is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). David Šálek collaborates with scholars based in Czechia, United States and France. David Šálek's co-authors include Andrea Janíková, Marek Trněný, David Belada, Jiřı́ Mayer, Robert Pytlík, Mojmír Moulis, Vít Procházka, Vít Campr, Tomáš Papajík and Jana Šmardová and has published in prestigious journals such as Blood, PLoS ONE and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

David Šálek

20 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Šálek Czechia 8 130 102 44 30 27 23 156
Mu‐Chen Zhang China 7 150 1.2× 109 1.1× 42 1.0× 57 1.9× 20 0.7× 16 210
Allison Barraclough Australia 8 106 0.8× 87 0.9× 30 0.7× 19 0.6× 21 0.8× 29 152
Joel Wight Australia 8 104 0.8× 58 0.6× 43 1.0× 24 0.8× 21 0.8× 22 157
Jesse Shustik Canada 5 114 0.9× 78 0.8× 50 1.1× 26 0.9× 16 0.6× 11 142
Farheen Mir United Kingdom 6 109 0.8× 74 0.7× 25 0.6× 46 1.5× 18 0.7× 13 167
Barbara Mantoan Italy 7 106 0.8× 71 0.7× 53 1.2× 28 0.9× 31 1.1× 13 155
Takayasu Kato Japan 6 94 0.7× 45 0.4× 44 1.0× 32 1.1× 21 0.8× 25 159
C. Bastard France 2 142 1.1× 85 0.8× 69 1.6× 56 1.9× 18 0.7× 5 179
Mitul Gandhi United States 8 133 1.0× 127 1.2× 80 1.8× 34 1.1× 24 0.9× 30 202
Anupkumar George Australia 4 100 0.8× 65 0.6× 54 1.2× 19 0.6× 22 0.8× 6 143

Countries citing papers authored by David Šálek

Since Specialization
Citations

This map shows the geographic impact of David Šálek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Šálek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Šálek more than expected).

Fields of papers citing papers by David Šálek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Šálek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Šálek. The network helps show where David Šálek may publish in the future.

Co-authorship network of co-authors of David Šálek

This figure shows the co-authorship network connecting the top 25 collaborators of David Šálek. A scholar is included among the top collaborators of David Šálek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Šálek. David Šálek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Móciková, Heidi, Andrea Janíková, Vít Procházka, et al.. (2024). Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data. Annals of Hematology. 104(1). 675–684.
2.
Klánová, Magdalena, et al.. (2023). Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?. Blood. 142(Supplement 1). 4479–4479. 1 indexed citations
3.
Obr, Aleš, Andrea Janíková, Heidi Móciková, et al.. (2022). Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic. Annals of Hematology. 102(1). 107–115. 4 indexed citations
4.
Obr, Aleš, Vít Procházka, Tomáš Papajík, et al.. (2018). Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Leukemia & lymphoma. 60(3). 748–755. 6 indexed citations
5.
Klener, Pavel, Eva Froňková, Markéta Kalinová, et al.. (2018). Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Hematological Oncology. 36(5). 773–778. 10 indexed citations
6.
Moulis, Mojmír, Barbora Ravčuková, Jitka Malčíková, et al.. (2017). Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. Oncology Reports. 38(4). 2535–2542. 12 indexed citations
7.
Moulis, Mojmír, et al.. (2016). Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas. Oncology Reports. 35(5). 2673–2680. 3 indexed citations
8.
Procházka, Vít, Tomáš Papajík, Andrea Janíková, et al.. (2016). Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database. Leukemia & lymphoma. 58(3). 601–613. 6 indexed citations
9.
Pytlík, Robert, Heidi Móciková, David Belada, et al.. (2016). Staging and Treatment Response Evaluation in Malignant Lymphomas – Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification). Klinicka onkologie. 29(4). 295–302. 6 indexed citations
10.
Procházka, Vít, Tomáš Papajík, Andrea Janíková, et al.. (2016). Early Progression after R-CHOP in Follicular Lymphoma: Key Role for the Maintenance Therapy. Blood. 128(22). 1779–1779. 1 indexed citations
11.
Stehlíková, Olga, et al.. (2015). Detection of minimal residual disease in mantle cell lymphoma-establishment of novel eight-color flow cytometry approach. Cytometry Part B Clinical Cytometry. 88(2). 92–100. 9 indexed citations
12.
Tonar, Zbyněk, David Šálek, Samuel Vokurka, et al.. (2014). Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(5). 587–597. 10 indexed citations
13.
Procházka, Vít, Robert Pytlík, Andrea Janíková, et al.. (2014). A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent. PLoS ONE. 9(7). e102594–e102594. 21 indexed citations
14.
Stehlíková, Olga, et al.. (2014). Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry Part B Clinical Cytometry. n/a–n/a. 7 indexed citations
15.
Trněný, Marek, Pavel Klener, David Belada, et al.. (2014). The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI). Blood. 124(21). 4425–4425. 2 indexed citations
16.
17.
Tůmová, Jana, et al.. (2013). Vitamin D insufficiency is not associated with diseaseaggressivity in newly diagnosed non-Hodgkin lymphoma patients. 1 indexed citations
18.
Janíková, Andrea, Boris Tichý, Kateřina Staňo Kozubík, et al.. (2010). Gene expression profiling in follicular lymphoma and its implication for clinical practice. Leukemia & lymphoma. 52(1). 59–68. 7 indexed citations
19.
Janíková, Andrea, Boris Tichý, Pavel Fabián, et al.. (2010). The Mystery of FDG-PET Avidity In Follicular Lymphoma. Does Microenvironment Play the Key Role?. Blood. 116(21). 4138–4138. 2 indexed citations
20.
Šmardová, Lenka, Ingrid Vášová, Milan Navrátil, et al.. (2008). Burkittův lymfom: přehled patofyziologie, diagnostiky a terapie.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mu‐Chen Zhang Breakdown of academic impact, for papers by Allison Barraclough Breakdown of academic impact, for papers by Joel Wight Breakdown of academic impact, for papers by Jesse Shustik Breakdown of academic impact, for papers by Farheen Mir Breakdown of academic impact, for papers by Barbara Mantoan Breakdown of academic impact, for papers by Takayasu Kato Breakdown of academic impact, for papers by C. Bastard Breakdown of academic impact, for papers by Mitul Gandhi Breakdown of academic impact, for papers by Anupkumar George
Rankless by CCL
2026